Daratumumab with bortezomib, lenalidomide and dexamethasone for untreated multiple myeloma when an autologous stem cell transplant is suitable [ID6249]

  • In development
  • GID-TA11254
  • Expected publication date: 

Documents

Documents created during the development process.

Draft guidance: 2

Declaration of interests

Draft guidance

Committee meetings

  • Committee meeting: 1

  • Committee meeting: 2

  • Committee meeting: 3

Invitation to participate

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6249